Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats

被引:86
作者
Hwa, JJ
Ghibaudi, L
Gao, J
Parker, EM
机构
[1] Schering Plough Corp, Res Inst, CNS CV Biol Res, Kenilworth, NJ 07033 USA
[2] Schering Plough Corp, Res Inst, Dept Cent Nervous Syst & Cardiovasc Res, Kenilworth, NJ 07033 USA
关键词
obesity; indirect calorimetry; oxygen consumption; respiratory quotient; agonist; antagonist;
D O I
10.1152/ajpregu.2001.281.2.R444
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Melanocortins play a critical role in appetite and body weight regulation, because manipulations of this pathway can lead to the development of obesity in several animal models. The purpose of this study was to use a melanocortin receptor agonist and antagonist to evaluate the involvement of melanocortins in feeding, energy metabolism, and body weight regulation in lean and obese Zucker rats. Central administration of a melanocortin receptor antagonist (SHU9119) elevated food intake and body weight of lean Zucker rats but had little effect in obese Zucker rats. In contrast, the melanocortin receptor agonist MTII reduced food intake in both lean and obese rats but was more potent in the obese Zucker rats. These data indicate the existence of functional melanocortin receptors in both lean and obese Zucker rats but suggest that obese Zucker rats have reduced endogenous melanocortin tone. In addition to its effects on food intake, MTII infusion elevated oxygen consumption and decreased respiratory quotient dose dependently during the light cycle. Our data suggest that a melanocortin receptor agonist can induce weight loss by increasing energy expenditure and promoting body fat utilization in addition to its inhibitory effects on food intake in both obese and lean Zucker rats.
引用
收藏
页码:R444 / R451
页数:8
相关论文
共 48 条
[41]   Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene [J].
Sina, M ;
Hinney, A ;
Ziegler, A ;
Neupert, T ;
Mayer, H ;
Siegfried, W ;
Blum, WF ;
Remschmidt, H ;
Hebebrand, J .
AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (06) :1501-1507
[42]   Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides [J].
Tatro, JB .
NEUROIMMUNOMODULATION, 1996, 3 (05) :259-284
[43]   Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice. [J].
Thornton, JE ;
Cheung, CC ;
Clifton, DK ;
Steiner, RA .
ENDOCRINOLOGY, 1997, 138 (11) :5063-5066
[44]   Two important systems in energy homeostasis: melanocortins and melanin-concentrating hormone [J].
Tritos, NA ;
Maratos-Flier, E .
NEUROPEPTIDES, 1999, 33 (05) :339-349
[45]   Effects of leptin and cholecystokinin in rats with a null mutation of the leptin receptor Leprfak [J].
Wildman, HF ;
Chua, S ;
Leibel, RL ;
Smith, GP .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2000, 278 (06) :R1518-R1523
[46]   Physiological and anatomical circuitry between Agouti-related protein and leptin signaling [J].
Wilson, BD ;
Bagnol, D ;
Kaelin, CB ;
Ollmann, MM ;
Gantz, I ;
Watson, SJ ;
Barsh, GS .
ENDOCRINOLOGY, 1999, 140 (05) :2387-2397
[47]   Characterization of Agouti-related protein binding to melanocortin receptors [J].
Yang, YK ;
Thompson, DA ;
Dickinson, CJ ;
Wilken, J ;
Barsh, GS ;
Kent, SBH ;
Gantz, I .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (01) :148-155
[48]  
ZURLO F, 1990, AM J PHYSIOL, V259, P650